Abstract. The role of acetylcholine receptors in the control of chick myoblast fusion in culture has been explored. Spontaneous fusion of myoblasts was inhibited by the nicotinic acetylcholine receptor antagonists ct-bungarotoxin, Naja naja toxin and monoclonal antibody mcAb 5.5. The muscarinic antagonists QNB and n-methyl scopolamine were without effect. Atropine had no effect below 1 p.M, where it blocks muscarinic receptors; at higher concentrations, when it blocks nicotinic receptors also, atropine inhibited myoblast fusion. The inhibitions imposed by acetylcholine receptor antagonists lasted for ~12 h; fusion stimulated by other endogenous substances then took over.
control of chick myoblast fusion in culture has been explored. Spontaneous fusion of myoblasts was inhibited by the nicotinic acetylcholine receptor antagonists ct-bungarotoxin, Naja naja toxin and monoclonal antibody mcAb 5.5. The muscarinic antagonists QNB and n-methyl scopolamine were without effect. Atropine had no effect below 1 p.M, where it blocks muscarinic receptors; at higher concentrations, when it blocks nicotinic receptors also, atropine inhibited myoblast fusion. The inhibitions imposed by acetylcholine receptor antagonists lasted for ~12 h; fusion stimulated by other endogenous substances then took over.
The inhibition was limited to myoblast fusion. The increases in cell number, DNA content, the level of creatine phosphokinase activity (both total and musclespecific isozyme) and the appearance of heavy chain myosin, which accompany muscle differentiation, followed a normal time course. Pre-fusion myoblasts, fusing myoblasts, and young myotubes specifically bound labeled ¢t-bungarotoxin, indicating the presence of acetylcholine receptors. The nicotinic acetylcholine receptor agonist, carbachol, induced uptake of [14C]Guanidinium through the acetylcholine receptor. Myoblasts, aligned myoblasts and young myotubes expressed the synthetic enzyme Choline acetyltransferase and stained positively with antibodies against acetylcholine. The appearance of ChAT activity in myogenic cultures was prevented by treatment with BUDR; nonmyogenic cells in the cultures expressed ChAT at a level which was too low to account for the activity in myogenic cultures. We conclude that activation of the nicotinic acetylcholine receptor is part of the mechanism controlling spontaneous myoblast fusion and that myoblasts synthesize an endogenous, fusion-inducing agent that activates the nicotinic ACh receptor.
I
N the previous paper we reported that agents that probably bring about depolarization of fusion competent myoblasts can initiate myoblast fusion (Entwistle et al., 1988) . In all cases, these agents were only effective when calcium ions were able to cross the membrane, suggesting that depolarization may open voltage-gated calcium channels. The resultant entry of calcium ions triggers myoblast fusion.
There is already evidence for prostanoids as an important endogenous stimulus for myoblast fusion (Entwistle et al., 1986) , possibly generating depolarization by increasing the permeability to chloride ions (Entwistle et al., 1988) . In the course of these experiments we showed that an agonist at the acetylcholine receptor, carbachol, also was able to initiate myoblast fusion, through a separate pathway from that triggered by prostanoids. Acetylcholine receptors appear at high density in the myoblast membrane after myotube formation (see Fambrough, 1979 for review) but are present on chick myoblasts at low density and can be detected either electrophysiologically or by the binding of [12~I]ct-bungarotoxin (Smilowitz and Fischbach, 1978) . In this paper we beled cultures were fixed in 4% glutaraldehyde in phosphate buffer at room temperature for 1 h, washed, dehydrated through a graduated series of methanols, and then air dried. The cultures were coated with a thin film of nuclear gel emulsion (Ilford K2, diluted 1:1 with water at 40°C) and exposed at 4°C for 4-28 d before development.
Assay of Choline Acetyl Transferase Activity
Choline acetyl transferase activity was determined using the method of Fonnum (1975) , modified to take account of the low levels of activity pertaining in cultured myoblasts. The dishes were rapidly rinsed twice with ice cold, 50 mM phosphate buffer containing 10 mM EDTA, made up to isotonicity with sodium chloride, at pH 7.4, followed by a rinse in the same solution, but lacking EDTA. Cells were gently scraped from the bottom of the dish with a silicone rubber stopper and harvested in 250 I.tl of EDTA-free buffer in an Eppendorf tube. The tubes were spun for 4 min at 500 g and most of the supernatant removed, leaving a total volume of ~27 ~1.1 p.l of EDTAfree buffer containing either 5 U of acetylcholine esterase or 1 mM physostigmine was then added to each tube. Total protein was assayed in parallel by the micro-assay of Bradford (1976) to assess cell loss during these procedures.
The reaction was started by adding 0.09 ~tCi [~4C]acetyl CoA (Amersham) in 2 I.tl of EDTA-free buffer containing 1 mM acetyl CoA (Sigma Chemical Co.), 40 mM choline chloride and 2.5% Triton X-100 (vol/vol) which gives a final concentration of choline of 2.7 mM. The Triton ensured efficient cell lysis. The mixture was incubated for 15 min at 37°C and the reaction stopped with 2.5 ml of ice cold EDTA containing buffer at pH 7.0. A 100-pl aliquot of the suspension was taken for protein assay. The remainder received 1 ml of 1% (wt/vol) tetraphenylboron in acetonitryl (BDH) followed by 4 ml of scintiUation fluid (Ready-solv, Beckman). It was then vortex-mixed, spun at 3,500 g for 113 min, and the aqueous phase removed with a silanized Pasteur pipette. The organic phase was counted in a Beckman Model LS 7500 or LS 1801 liquid scintillation counter. A blank set of dishes was carried through the same procedures to assess the amount of Acetyl CoA partitioned into the organic phase. ChAT activity was calculated from the difference in radioactivity between dishes treated with physostigmine and those treated with acetylcholine esterase. The results are expressed as pmol/min per mgm protein on the basis of the protein content determined in the aliquots taken before counting.
To determine carnitine acetyltransferase activity, 10 mM carnitine (final concentration) was substituted for choline in the assay described above and the reaction stopped with ice-cold EDTA in buffer at pH 3.0 to enhance the entry of acetylcarnitine into the organic phase. The activity in myoblasts was calculated by comparison with a standard curve constructed using pigeon breast carnitine acetyltransferase (Sigma Chemical Co.). If the reaction was stopped with EDTA buffered at pH 7.0, as for choline, the level of activity in the organic phase fell to background levels, confirming that the extraction method normally excludes acetylcarnitine (Fonnum, 1975; Tucek et al., 1978) . By contrast, in controls using labeled acetylcholine more than 80% of the initial radioactivity was partitioned into the organic phase; this was abolished by the inclusion of AChE in the incubation medium.
lmmunocytochemistry
The appearance of the muscle-specific form of Creatine phosphokinase and of the myosin-heavy chain was detected with antibodies using a double staining technique. A rabbit polyclonal antibody to the muscle specific CPK isozyme was kindly donated by J. C. Perriard (University of Zurich, Zurich, Switzerland); a mouse monoclonal myosin antibody came from G. Dhoot (University of Birmingham, Birmingham, U.K.). The cultures were fixed in 1:1 acetone/methanol at -20°C for 1.5 min, air dried, and stored at 4°C. For assay each dish was preincubated at 37°C with 1 ml PBS, pH 7.4, containing 10% horse serum, rinsed thoroughly with PBS and then incubated for 1 h at 37°C in a high humidity atmosphere with 1:100 dilution of the anti-muscle specific CPK antibody. They were then rinsed thoroughly with PBS and incubated with a fluoresceinated anti-rabbit second layer antibody for 1 h under the same conditions. After further rinsing, the anti-myosin monoclonal antibody (1:100) was applied for 1 h. The myosin specific antibody was rinsed away and a rhodaminated, anti-mouse second layer applied, again for 1 h. After further rinsing the cultures were mounted in anti-fade mountant (Citifluor, City of London Polytechnic, London, U.K.) and viewed at 300× magnification through the appropriate filters in a Zeiss IIIRS microscope equipped for epi-fluorescence. The cytoplasm surrounding 200-300 nuclei from each culture, taken across the radius of the dish, were scored for the number showing positive staining, and the results then expressed as the percentage of nuclei in each dish surrounded by positively staining cytoplasm. Controls using the second layer antibodies alone showed no specific staining. Cultures were scored blind in order to avoid subjective bias.
Immediately pre-fusion and aligned myoblasts (50 h of culture) were stained for acetylcholine with a rabbit polyclonal antibody against glutaraldehyde conjugated acetylcholine (Biosoft, France; Geffard et al., 1985) . The cultures were fixed for 1 rain in 2% formalin with 0.5 M allyl alcohol and 0.15 M cacodylate buffer, post-fixed in the absence of allyl alcohol for 15 min, and then washed thoroughly with 0.1 M phosphate buffer. They were stained with the ACh antibody (1:100) in phosphate buffer with 0.1% Triton X-100 and 2% FCS (1:200) for 1.5 h, washed, then exposed to biotinylated goat anti-rabbit antibodies (1:200) for 1 h, washed thoroughly, and exposed to FITC-coupled Streptavidin for 1 h, washed thoroughly with phosphate buffer and mounted in anti-fade mountant. No specific staining was observed in controls using second layer antibodies only, when allyl alcohol was omitted from the fixative or if the cells were treated with Triton X-100 before fixation. DNA content and total Creatine phosphokinase activity were determined as described in Entwistle et al. (1986) .
Guanidinium Uptake and Efflux
10 -s M ct-bungarotoxin was added to one set of dishes containing myoblasts 30 h after plating 1 h before uptake measurement began. Immediately before the uptake measurements the culture medium was replaced by 700 ~tl isotonic-buffered sucrose (290 mM sucrose, 20 mM glucose, 5.4 mM KCI, 10 mM Hepes, set to pH 7.4 with Tris base). At time zero 48 t.tCi of [t4C]guanidinium (specific activity 48 mCi/mmol, Amersham International, U.K.) and sufficient carbachol to bring the final concentration to 10 -s M were added to all dishes. 30 s later 4 dishes were taken from each set, rapidly, but gently, rinsed 7 times to remove the loading solution, and 1 ml buffered sucrose containing Triton X-100 (0.1%) added to lyse the cells. Further sets of dishes were similarly treated at 1, 2, and 4 min after the addition of labeled medium. The solution from each dish was taken up into 3 ml of Ready-solv and counted in a liquid scintillation counter. The amounts of radioactivity contained by the cells at each time point were used to construct an uptake curve and the carbachol-induced uptake of guanidinium calculated as the difference between the uptake curves in the absence and presence of a-bungarotoxin.
Guanidinium efflux measurements were made on immediately pre-fusion myoblasts and young myotubes. The cultures were exposed to [3H]guanidinium for 4-12 h to load them to equilibrium. They were rapidly rinsed five times to remove labeled guanidinium from the extracellular space and at time zero 1 ml of unlabeled medium of the same composition as the load solution added to each dish. The wash solution was withdrawn and replaced with 1 ml new solution at 15 s, 0.5-or 1-min intervals and after a steady effiux rate had been established solution containing 10-500 ~M o-tubocurare was added to the dish. Four samples were taken in the presence of dTc and the effiux solution then returned to normal medium. At the end of the efflux measurements the cells were lysed by the addition of 1 ml 0.1% Triton X-100 and the lysate counted to provide the radioactivity remaining within the cells. The rate constant (k) was calculated from the ratio of the effiux of radioactivity/min and the appropriate cumulative activity of the cells.
Results

Blocking the Nicotinic Acetylcholine Receptor Delays Myoblast Fusion
When myoblast fusion has been delayed by preventing synthesis of prostanoids, fusion can be induced by the acetylcholine agonist, carbachol. The fusion-inducing effect of carbachol is blocked by the nicotinic acetylcholine receptor blocker, ct-bungarotoxin, which does not affect fusion induced by the addition of Prostaglandin E~ (PGE0 ~ (Entwistie et al., 1987) . Fig. 1 a shows that a-bungarotoxin can also prevent spontaneous myoblast fusion, assessed at 54 h of culture, when 40-50% fusion has taken place in controls, in a concentration-dependent manner. Inhibition was obvious at 10 -9 M and maximal at 10 -s M. Cell number and myoblast alignment were unaffected. In keeping with the results mean of four culture dishes mcAb 5.5 (/~g/ml) and the bars +1 SD.
reported in the previous paper, either the addition of PGE~ ( Fig. 1 a, open square) or raising potassium to 20 mM ( Fig.  1 a, open circles) overcame the block imposed by ct-bungarotoxin, initiating fusion at the level observed in uninhibited, parallel cultures ( Fig. 1 a, solid square) . In this particular experiment fusion induced by potassium was substantially (fusion index 1.4) greater than spontaneous fusion. This was very unusual. In all other experiments, potassium often caused a small (10-15%) stimulation of fusion, although there was no evidence for the induction of precocious fusion (see Entwistle et al., 1988) . The reason for the substantial stimulatory effect of potassium in this experiment is not known. Another snake neuro-toxin, Naja naja toxin, that also binds to nicotinic acetylcholine receptors, was similarly effective in preventing spontaneous fusion of myoblasts ( Fig.  1 b) . Both these snake toxins can bind tightly to sites other than acetylcholine receptors in some cell types (e.g., PC12 cells, Patrick and Stallcup, 1977) . Fig. 1 
c, (solid circles)
shows that a monoclonal antibody (mcAb 5.5), which binds to and inactivates nicotinic acetylcholine receptors in chick muscle (Goldberg et al., 1983) , was also able to inhibit spontaneous myoblast fusion, the block again being overcome by the addition of 20 mM potassium (open circles). The inhibition of spontaneous fusion achieved by blockers of nicotinic acetylcholine receptors was not complete and a low level of fusion, '~10-15 %, took place nevertheless (see Fig. 1 a) . This low level of spontaneous fusion is similar to that found when myoblast fusion is delayed by inhibiting prostanoid synthesis (Entwistle et al., 1986) . Myoblasts eventually escaped from the inhibition of fusion imposed by blocking the nicotinic acetylcholine receptor. . At 54 h of culture fusion in toxin-containing cultures was still less than 15%, compared with 42 % in the parallel, untreated cultures. However by 57 h, fusion in toxin treated cultures had reached 32 % and by 60 h it was no longer any different from the untreated control. This suggests that during the inhibition there is a build-up of fusion-inducing agents other than those activating the nicotinic acetylcholine receptor that eventually overcomes the toxin-induced block. A similar escape occurred during treatment with Naja naja toxin and was noted previously during inhibition of prostanoid synthesis (Entwistie et al., 1986) . Repeated dosing with any of the acetylcholine receptor blockers was unable to prolong the time course of the block, suggesting that the escape did not arise because of toxin coming off the cells. Furthermore, treatment with both prostanoid synthesis inhibitors and blockers of the acetylcholine receptor was unable to prevent the eventual initiation of spontaneous myoblast fusion. As noted previously (Entwistle et al., 1988) , myoblast fusion must then proceed by yet another route. All values give the mean + 1 SD of four dishes. In each case the drug was added after 24 h in culture and the assay carried out at 52 h of culture. A second dose of QNB 10 -6 was added at 42 h. Table I shows that antagonists to muscarinic acetylcholine receptors (atropine, quinuclidinylbenzilate [QNB] , and N-methyl scopolamine) had little or no effect on myoblast fusion when applied at concentrations which would be expected to block specifically muscarinic receptors. However, atropine concentrations above 1 IxM, where block of nicotinic acetylcholine receptors is known to occur (Feltz et al., 1977) , did suppress myoblast fusion. In 5 experiments (20 dishes) control fusion was 45.2 _ 2.8% (+1 SEM). In the presence of 1 ~ Atropine, fusion fell to 14.5 + 4.3% (+1 SEM, n = 5, 20 dishes). Taken together these results confirm that nicotinic, rather than muscarinic, acetylcholine receptors are involved.
If activation of nicotinic acetylcholine receptors is involved in myoblast fusion, then o-tubocurare, a well known antagonist of acetylcholine at the neuromuscular junction, might be expected to prevent the spontaneous fusion of myoblasts. However no inhibition of fusion was found with 10 -3 or 10 -6 M o-tubocurare. Fig. 3 
(open circles).
The agonist action of n-tubocurare could be prevented by a-bungarotoxin (10 -8 M). This apparently anomalous finding might be explained if the drug acts as an agonist to the acetylcholine receptor on chick myoblasts, as described in rat myoblasts and young myotubes (Trautman, 1982; Takeda and Trautman, 1984) . Experiments to test this possibility directly were made by following the efflux of guanidinium ions, which can permeate the ACh receptor activated channel, in the absence and presence of 10-500 lxM n-tubocurare. On some occasions a significant efflux of guanidinium ions was induced by dTC and reduced by ct-bungarotoxin, consistent with an agonist action at the ACh receptor. The variability of the response could arise if the agonist action was short-lived and followed by antagonistic effects. However these experiments do not exclude the possibility that dTC induces myoblast fusion by some completely separate mechanism.
Nicotinic Acetylcholine Receptor Blockers do not Inhibit Myoblast Differentiation
Although nicotinic antagonists delayed myoblast fusion, the block could be completely overcome by raising extracellular potassium or the addition of PGE,. This suggests that the inhibition operates at the level of myoblast fusion, rather than reflecting a general effect on myoblast differentiation. This is supported by measurements of several other properties of myoblasts that are known to change in the course of normal myogenesis in vitro. Table II shows that at 54 h of culture cholinergic antagonists had no effect on the changes in the cell number, DNA content, level of total creatine phosphokinase (CPK) activity, appearance of the muscle specific CPK isozyme and the appearance of myosin heavy chains 
take (minutes). (Open circles)
Uptake of guanidinium in the presence of 10 gM carbaehol. that accompany normal myoblast differentiation. When assessing the proportion of nuclei surrounded by cytoplasm positively stained for the CPK isozyme or myosin heavy chains, no specific precautions were taken to differentiate between fused and unfused myoblasts since cultures containing predominantly unfused cells nevertheless showed a high proportion of positive staining.
(Open squares)
Myoblasts Possess a-Bungarotoxin-binding Sites and Functional Acetylcholine Receptors
The appearance and distribution of ¢t-bungarotoxin-binding sites, was determined by autoradiography of myoblast cultures exposed to ~5I-labeled a-bungarotoxin. Fig. 4 shows sample autoradiographs made from myoblast cultures before fusion begins (30 h), at the beginning of the main burst of spontaneous fusion (48 h), and after the formation of myotubes (144 h). Bipolar, single cells in both 30-and 48-h cultures bound ct-bungarotoxin (Fig. 4, a-f) , although fibroblasts did not. At 30 h 23.7 -l-2.8% (mean +SEM; 3 dishes) of solitary bipolar cells showed clear ct-bungarotoxin-binding, while a higher percentage (53.3 + 4.0%; mean +SEM; 3 dishes) of aligned myoblasts were labeled. At 48 h aligning myoblasts (Fig. 4 , g and h) again showed specific binding of labeled toxin, although not all cells were labeled. After 144 h in culture, when extensive chains of myotubes had formed, both diffuse toxin binding and hot spots were evident (Fig.   4, i and j) . Comparison of the level of binding sites in myotubes ( Fig. 4j) with that in single myoblasts (Fig. 4, b and  d) shows that some myoblasts possess a high density of toxinbinding sites, similar to that in formed myotubes. The binding of a-bungarotoxin could be prevented if either carbachol (10 -3 M) or D-tubocurare (10 -3 M) was included in the medium during labeling. For acetylcholine to be a plausible fusion-inducing stimulus during myogenesis in culture, it is necessary to show that the myoblast membrane contains functional nicotinic acetylcholine receptors. We therefore tested whether carbachol was able to produce an increase in the sodium permeability of pre-fusion myoblasts. The uptake of [t4C]guanidinium, which has been shown to permeate through acetylcholine receptors channels in skeletal muscle (Dwyer et al., 1980) , was used to indicate the uptake of sodium. The experiments were made on myoblast cultures at 30 h in culture. 
Myoblasts Express Choline Acetyltransferase Activity and Bind ACh Antibodies
The finding that blocking nicotinic acetylcholine receptors can delay the spontaneous fusion of cultured myoblasts raises the possibility that some cells in the cultures, possibly myoblasts themselves, synthesize and release acetylcholine or a similar agonist. To test whether myoblasts might be able to synthesize acetylcholine, cultures of myoblasts and myotubes were assayed for the presence of the synthetic enzyme choline acetyltransferase (CHAT) using a modification of an existing procedure (see Materials and Methods).
Control experiments showed that the endogenous level of carnitine acetyltransferase activity, which might complicate estimates of ChAT activity (Rossier, 1977; Goodman et al., 1984) , in myoblasts after 50 h of culture was 378 5:75 IxU/culture dish (416 + 8 lxU/mgm protein, n = 6). The synthesis of acetylcarnitine was not sensitive to acetylcholine- (6) 383 ± 33 (6) 0.9 ± 0.9
Each figure gives the mean + 1 SD with the number of replicates in parentheses. * Activity in the presence of physostigmine significantly greater than in the presence of AChE (P < 0.05; Mann-Whitney Test. Cells were plated at a density of 8 x 104/sq cm BUDR (1 × 10 -5 M) added at 6 h of culture and again at the medium change (24 h).
esterase, as seen previously (Blum et al., 1971; Hamprecht and Amano, 1974) . When 1 mU of pigeon breast muscle carnitine acetyltransferae (twice the endogenous level at 50 h) was incubated with 2.7 mM choline as in the standard assay (see Materials and Methods), the activity in the organic phase was no different from background. 10 mU earnitine acetyltransferase gave detectable levels of radioactivity (*5 times background). The outcome of ChAT assays is shown in Table III . In 50-h cultures of myoblasts, when fusion is just beginning, the organic phase clearly contained detectable radioactivity, which was abolished completely by the inclusion of AChE in the incubation medium. This suggests that at 50 h the cells possess ChAT activity, Cultures treated with bromodeoxyuridine (BUDR) showed a low level of activity, which was not sensitive to incubation with ACHE, suggesting that ChAT levels were much reduced. At 96 h, by which time fusion should be maximal, the myoblasts showed an increased level of AChE sensitive activity, suggesting that ChAT activity was maintained although acetylation of choline by increased levels of carnitine acetyltransferase cannot be ruled out (see Goodman et al., 1984) . The esterase insensitive activity increased also, which would be consistent with a concomitant rise in carnitine acetyltransferase activity or endogenous levels of carnitine. Older cultures containing myotubes (144 h) retained significant levels of AChE sensitive activity, while there was little increase in the activity expressed in the presence of ACHE. Table HI shows also that ChAT activity in cultures of fibroblast-like cells, derived from myogenic cultures by repeated sub-passaging, was substantially lower than in the myoblast cultures, making it unlikely that the ChAT activity in the myoblast cultures came from contaminating fibroblasts.
These measurements indicate that myoblasts at the time of fusion and, possibly, myotubes possess choline acetyltransferase activity.
Although it is likely that the radioactive compound extracted into the organic phase in these experiments was acetylcholine, this remains to be proved. As an alternative, we tested whether cultures at 50 h, which contain bipolar myoblasts, aligning myoblasts, and the earliest myotubes, specifically bound antibodies to acetylcholine. Fig. 6 shows photographs of bipolar myoblasts and aligned myoblasts which show specific binding of an antibody to ACh (a-d), compared with binding in controls in which allyl alcohol was omitted from the fixative (g) or Triton X-100 was applied before fixation (e and f). Epithelial cells showed no specific binding of ACh antibodies (arrows in a and b). Thus it is likely that bipolar myoblasts and aligning myoblasts not only possess ChAT activity, but also synthesize acetylcholine.
Discussion
This paper provides evidence that myoblasts in culture are provoked to fuse and form myotubes by activation of the nicotinic acetylcholine receptor; an agonist at the ACh receptor could be an endogenous fusion-inducing substance. Thus spontaneous fusion can be delayed by blocking nicotinic acetylcholine receptors, pre-fusion myoblasts possess ct-bungarotoxin-binding sites and activation of myoblast acetylcholine receptors produces an increase in membrane permeability to guanidinium ions, which are known to permeate the ACh channel in the same way as sodium. Furthermore pre-fusion myoblasts specifically bind antibodies to ACh and express the enzyme CHAT, which is associated with the synthesis of acetylcholine (Moolenar and Polak, 1980; Miledi et al., 1982) . The ionic basis of myoblast fusion induced by activation of the acetylcholine receptor was discussed in the previous paper (Entwistle et al., 1988) and is not reconsidered here.
The identification of the nicotinic, rather than the muscarinic, acetylcholine receptor as the mediator of myoblast fusion rests on comparison of the ability of known nicotinic and muscarinic acetylcholine receptor antagonists to inhibit spontaneous myoblast fusion. Of the muscarinic antagonists, atropine was able to delay myoblast fusion, but only at concentrations well above those at which it blocks muscarinic receptors in other tissues, when it is known also to bind to nicotinic receptors (Feltz et al., 1977) . Further support comes from the specific binding of labeled a-bungarotoxin to prefusion myoblasts and the finding that toxin binding could be prevented by carbachol and o-tubocurare.
The inhibition of myogenesis imposed when the nicotinic acetylcholine receptor is blocked is restricted to the prevention of myoblast fusion. Cell division and the alignment of myoblasts in preparation for fusion are unaffected, as is the increase in creatine phosphokinase activity and the appearance of myosin, which are both considered to reflect early steps in muscle differentiation. The block is therefore very similar to that achieved by inhibiting prostanoid synthesis (Entwistle et al., 1986) . These observations support a growing body of evidence that the link between myotube formation and the differentiation of the phenotypic properties of muscle can be dissociated. Thus blocking the acetylcholine receptor, inhibiting prostanoid synthesis and lowering external calcium to ~1/10 of its normal level (see Entwistle et al., 1988) all seem to affect the fusion process alone. Manipulation of the ionic environment also can either prevent or promote fusion depending on the particular conditions chosen (see Entwistle et al., 1988) . The ability to separate these two processes in a variety of ways should aid analysis of the underlying control mechanisms.
Carbachol induced an ct-bungarotoxin sensitive, uptake of guanidinium ions in fusing myoblasts. This is the counterpart to the demonstration that sodium ions must be present in the medium for the acetylcholine agonist to act as a fusioninducing agent (Entwistle et al., 1988) and reinforces the suggestion that depolarization of the myoblast membrane is an integral part of the initiation of myoblast fusion (Entwistle et al., 1988) .
Both myoblasts and myotubes express enzyme activity that is probably, although not certainly, choline acetyltransferase. The partition of ACh into tetraphenylboron at pH 7.0 has been shown to be specific (Fonnum, 1975; Tucek et al., 1978) and myoblasts were labeled specifically with an antibody to acetylcholine. It is unlikely that contaminating fibroblasts are the source of acetylcholine in the cultures because they contain much less ChAT than myoblasts and did not bind the ACh antibody. In addition, fibroblasts form a relatively small proportion of the cells in the cultures, since 80% of cells are destined to form myotubes, setting the maximal likely contamination with non-myogenic cells at 20%.
The Control of Spontaneous Myoblast Fusion
Evidence has been accumulating that prostanoids may be in-volved in myoblast differentiation and fusion (Zalin, 1977; Entwistle et al. 1986; David and Higginbotham, 1981) . Part of this evidence rests on the finding that spontaneous fusion of myoblasts in culture is substantially delayed when prostanoid synthesis is inhibited. The observation that blocking the acetylcholine receptor also substantially delays spontaneous fusion poses a number of questions about the control of myoblast fusion both in vitro and in vivo. The two pathways can be activated independently. However the effective concentration for PGErinduced fusion is increased when the acetylcholine receptor is blocked (Entwistle et al., 1988) and preventing activation through either pathway is sufficient to delay spontaneous fusion in vitro (this paper and Entwistle et al., 1988) . This suggests that cultured myoblasts produce subthreshold amounts of more than one fusion-inducing agent and the two pathways act synergistically during spontaneous fusion. One of these agents is probably a prostanoid (Zalin, 1977; Entwistle et al. 1986; David and Higginbotham, 1981) . The other acts at the nicotinic ACh receptor and might be acetylcholine itself, although the present results do not allow its unequivocal identification. The situation during normal development is more difficult to define. Prostaglandins and prostanoid-binding sites have been detected in differentiating myoblasts (Hausman et al., 1986; Zalin, 1987) .
Both innervated and denervated frog and rat muscle have been shown to synthesize acetylcholine (Miledi et al., 1977 (Miledi et al., , 1978 (Miledi et al., , 1981 , although its functional role has not been identified. The presence of ChAT activity in young myotubes would not, therefore, be totally unexpected. However, the demonstration of ChAT activity does not, in itself, mean that either myoblasts or myotubes are synthesizing acetylcholine. The activity could be masked functionally and only released from the inactive form during the lysis necessary to carry out the assay. The finding that myoblasts bind specifically an acetylcholine antibody is more convincing. Muscle synthesized acetylcholine may persist for some time and could assist the accretion of myoblasts during myotube formation.
The earliest motoneurons enter the muscle mass very early in development (Landmesser, 1978) and may secrete acetylcholine during neurite elongation (Young and Pod, 1984) . Thus the present findings raise the interesting possibility that neurons have a role in myoblast fusion. It will be interesting to know whether young myotubes retain the ability to synthesize ACh after the arrival of the motoneuron, and whether the fusion-inducing effect of any ACh released from muscle is additive with that released by innervating motoneurons. However any involvement of neuronaUy released acetylcholine cannot be obligatory since differentiated muscles, albeit rather small in size, can be found in limbs deprived of motor innervation before the motor nerves have entered the limb. It is perhaps more plausible to suppose that neuronal activation of acetylcholine receptors may assist the continual accretion of myoblasts into myotubes and in the formation of secondary myotubes. Muscles formed in the absence of innervating motoneurons may be small not only because of the absence of electrically driven motor activity, but also because fewer myotubes are formed in these circumstances.
One consistent feature of the results is the gradual escape of the myoblasts from inhibitions of fusion imposed either by reducing prostanoid synthesis or by including blockers of nicotinic acetylcholine receptors in the culture medium. This suggests that myoblasts are able to fall back on yet another fusion-inducing mechanism which comes into play when fusion is greatly delayed. The present results shed no light on this auxiliary mechanism, but it could be related to the presence of membrane receptors to ATP (Kolk and Wakelam, 1983; Hume and Honig, 1986) and we now have evidence to suggest that this is the case (Entwistle and Bevan, manuscript in preparation) . The presence of three, apparently independent mechanisms each of which leads to myoblast fusion, implies that this event is of such importance during myogenesis that natural selection has ensured a very large safety factor. 
